Resultados de la búsqueda 631-640 of 20284 for Two-phase

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ALEX Study: A Randomized, Phase III Study ... Patients will be randomized 1:1 into the two arms. ... 2-6: 500 mg/m2). Patients randomized to B+R will ...

  2. Oncología (médica) - Ensayos clínicos

    ... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...

  3. Oncología (médica) - Ensayos clínicos

    Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase ... 2 drugs for the initial WT) and regimen ICE/Cyclo ... [1, 2] The solid tumor stroma acts as an ...

  4. Oncología (médica) - Ensayos clínicos

    BiCaZO: A Study Combining Two Immunotherapies ... (Stage I and Stage II). Additinoally, to ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety ...

  5. Oncología (médica) - Ensayos clínicos

    BiCaZO: A Study Combining Two Immunotherapies ... (Stage I and Stage II). Additinoally, to ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety ...

  6. Otorrinolaringología (oído, nariz y garganta) y cirugía de cabeza y cuello - Ensayos clínicos - Mayo Clinic

    ... two previously validated quality-of-life scales. ... (Stage I and Stage II). Additinoally, to evaluate the ... This phase II trial compares the impact of ...

  7. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    MC1733, Phase I Trial of Intratumoral ... The purpose of this study is to assess outcomes, satisfaction and aesthetics of two ... Ir a página 22 · Ir a ...

  8. Oncología (médica) - Ensayos clínicos

    ... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...

  9. Ensayos clínicos - Neurología

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

  10. Ensayos clínicos - Neurología

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...